U.S. clears use of Abbott drug for Crohn's disease
Tue, 27 Feb 2007 07:25 PM EST
... WASHINGTON (Reuters) - Abbott Laboratories Inc. won U.S. approval to promote its injectable arthritis drug Humira for treating patients with moderate to severe forms of Crohn's disease, health officials said on Tuesday. ...
Related Topics
- Crohn's Disease
- Adalimumab
- Drug Safety
- Prescription Drugs
- Diseases & Conditions
- Drug Side Effects
- Drug Abuse
- Drug Information
- Prescription Drug Abuse
- Prescription Drugs Abuse
- Heart Disease
- Bone Disease
- Lung Diseases & Disorders
- Huntington's Disease
- Kidney Disease
- Rare Diseases
- Graves' Disease
- Autoimmune Diseases
- Periodontal Disease
- Cardiovascular Diseases And Disorders

Not Signed In -


